BioWorld MedTech

Sep. 28, 2016

DEAL BOOSTS AMBULATORY SURGICAL OFFERINGS

Boston Scientific (NYSE: BSX) has agreed to buy Endochoice Holdings, an Alpharetta, Ga.-based company focused on endoscopy, in a deal valued at about $210 million. Read More

Expanding DCB market expected to exceed $800 million by 2020

India weighs mandatory UCPMP to curb unfair marketing practices

Mainstay Medical launches IDE trial to test 'pacemaker for back pain'

In final guidance, FDA says it wants tests of communication for patient preference data

Other news to note

Financings

Daily M&A

Product briefs

Appointments & advancements

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 8, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

GDE4 blockade promotes remyelination, study finds

BioWorld Science

Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...